Touchstone International Medical Science Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -15.35% vs 9.30% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -26.52% vs 15.79% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.70",
          "val2": "65.80",
          "chgp": "-15.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.00",
          "val2": "12.00",
          "chgp": "-58.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "1.10",
          "chgp": "-90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.70",
          "val2": "13.20",
          "chgp": "-26.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.80%",
          "val2": "136.60%",
          "chgp": "-4.68%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.01% vs 7.51% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 64.16% vs 9.73% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "324.50",
          "val2": "270.40",
          "chgp": "20.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.80",
          "val2": "56.70",
          "chgp": "49.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.40",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.50",
          "val2": "-1.90",
          "chgp": "547.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "85.20",
          "val2": "51.90",
          "chgp": "64.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "221.00%",
          "val2": "170.20%",
          "chgp": "5.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

55.70

65.80

-15.35%

Operating Profit (PBDIT) excl Other Income

5.00

12.00

-58.33%

Interest

0.20

0.00

Exceptional Items

0.10

1.10

-90.91%

Consolidate Net Profit

9.70

13.20

-26.52%

Operating Profit Margin (Excl OI)

89.80%

136.60%

-4.68%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -15.35% vs 9.30% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -26.52% vs 15.79% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

324.50

270.40

20.01%

Operating Profit (PBDIT) excl Other Income

84.80

56.70

49.56%

Interest

0.60

0.40

50.00%

Exceptional Items

8.50

-1.90

547.37%

Consolidate Net Profit

85.20

51.90

64.16%

Operating Profit Margin (Excl OI)

221.00%

170.20%

5.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 20.01% vs 7.51% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 64.16% vs 9.73% in Dec 2024

All Annual Results